INSILICO MEDICINE

insilico-medicine-logo

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases. It pioneered the applications of the generative adversarial networks (GANs), reinforcement learning, transfer learning, and meta-learning for the generation of novel molecular structures for the diseases with known and unknown targets, and, unlike the other companies in the field, is developing the end-to-end pipeline covering every step of drug discovery, clinical trials analysis, and digita... l medicine. Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging. Through a partnership with Life Extension, the company launched a range of nutraceutical products, which were compounded using advanced bioinformatics techniques and deep learning approaches. It also provides a range of consumer-facing applications including Young.AI.

#SimilarOrganizations #People #Financial #Event #Website #More

INSILICO MEDICINE

Social Links:

Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical

Founded:
2014-01-01

Address:
Hong Kong, Hong Kong Island, Hong Kong

Country:
Hong Kong

Website Url:
http://www.insilico.com

Total Employee:
101+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
401.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Euro COVID-19


Similar Organizations

3billion-logo

3billion

3billion is a world leader in the field of genetic diagnostics for rare disease.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

helixnano-logo

HelixNano

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.

fabric-genomics-formerly-omicia-logo

Fabric Genomics (formerly Omicia)

Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

kristen-fortney_image

Kristen Fortney Scientific Advisor @ Insilico Medicine
Advisor
2014-01-01

min-fang_image

Min Fang Board Member @ Insilico Medicine
Board_member

nisa-leung_image

Nisa Leung Board Member @ Insilico Medicine
Board_member

garri-zmudze_image

Garri Zmudze Business Advisor @ Insilico Medicine
Advisor
2016-04-01

Current Employees Featured

alex-zhavoronkov_image

Alex Zhavoronkov
Alex Zhavoronkov Founder & Chief Executive Officer @ Insilico Medicine
Founder & Chief Executive Officer
2014-03-01

qingsong-zhu_image

Qingsong Zhu
Qingsong Zhu COO @ Insilico Medicine
COO
2014-01-01

michelle-chen_image

Michelle Chen
Michelle Chen Chief Business Officer @ Insilico Medicine
Chief Business Officer
2021-10-01

robert-spiegel_image

Robert Spiegel
Robert Spiegel Chief Medical Officer @ Insilico Medicine
Chief Medical Officer
2021-09-01

alex-aliper_image

Alex Aliper
Alex Aliper President of EMEA @ Insilico Medicine
President of EMEA
2015-12-01

vladimir-naumov_image

Vladimir Naumov
Vladimir Naumov bioinformatics data scientist @ Insilico Medicine
bioinformatics data scientist
2020-04-01

not_available_image

Nirav Jhaveri
Nirav Jhaveri Chief Financial Officer @ Insilico Medicine
Chief Financial Officer
2021-01-01

feng-ren_image

Feng Ren
Feng Ren co-CEO @ Insilico Medicine
co-CEO
2022-06-01

polina-mamoshina_image

Polina Mamoshina
Polina Mamoshina Research Scientist @ Insilico Medicine
Research Scientist

Founder


alex-zhavoronkov_image

Alex Zhavoronkov

Investors List

b-capital-group_image

B Capital Group

B Capital Group investment in Series D - Insilico Medicine

bhr-partners_image

BHR Partners

BHR Partners investment in Series D - Insilico Medicine

prosperity7-ventures-d527_image

Prosperity7 Ventures

Prosperity7 Ventures investment in Series D - Insilico Medicine

wilson-sonsini-goodrich-rosati_image

Wilson Sonsini Goodrich & Rosati

Wilson Sonsini Goodrich & Rosati investment in Series D - Insilico Medicine

deerfield_image

Deerfield

Deerfield investment in Series D - Insilico Medicine

pavilion-capital_image

Pavilion Capital

Pavilion Capital investment in Series D - Insilico Medicine

warburg-pincus_image

Warburg Pincus

Warburg Pincus investment in Series D - Insilico Medicine

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series D - Insilico Medicine

bold-capital_image

Bold Capital Partners

Bold Capital Partners investment in Series D - Insilico Medicine

bold-capital_image

Bold Capital Partners

Bold Capital Partners investment in Series D - Insilico Medicine

Newest Events participated

nips-2018_event_image Participated in NIPS 2018 on 2018-12-03 as sponsor

women-in-machine-learning-dinner-london-2018_event_image Participated in Women in Machine Learning Dinner London 2018 on 2018-11-20 as sponsor

women-in-ai-in-healthcare-dinner-london-2017_event_image Participated in Women in AI in Healthcare Dinner, London 2017 on 2017-11-22 as sponsor

biodata-west_event_image Participated in BioData West on 2017-10-10 as sponsor

Official Site Inspections

http://www.insilico.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.88 K

  • Host name: 185.215.4.66
  • IP address: 185.215.4.66
  • Location: Denmark
  • Latitude: 55.7123
  • Longitude: 12.0564
  • Timezone: Europe/Copenhagen

Loading ...

More informations about "Insilico Medicine" on Search Engine